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Abstract
Background: PKQuest, a new physiologically based pharmacokinetic (PBPK) program, is applied
to human ethanol data. The classical definition of first pass metabolism (FPM) based on the
differences in the area under the curve (AUC) for identical intravenous and oral doses is invalid if
the metabolism is non-linear (e.g. ethanol). Uncertainties in the measurement of FPM have led to
controversy about the magnitude of gastric alcohol metabolism. PKQuest implements a new,
rigorous definition of FPM based on finding the equivalent intravenous input function that would
produce a blood time course identical to that observed for the oral intake. This input function
equals the peripheral availability (PA) and the FPM is defined by: FPM = Total oral dose – PA.
PKQuest also provides a quantitative measurement of the time course of intestinal absorption.
Methods: PKQuest was applied to previously published ethanol pharmacokinetic data.
Results: The rate of ethanol absorption is primarily limited by the rate of gastric emptying. For
oral ethanol with a meal: absorption is slow ( 3 hours) and the fractional PKQuest FPM was 36%
(0.15 gm/Kg dose) and 7% (0.3 gm/Kg). In contrast, fasting oral ethanol absorption is fast ( 50
minutes) and FPM is small.
Conclusions: The standard AUC and one compartment methods significantly overestimate the
FPM. Gastric ethanol metabolism is not significant. Ingestion of a coincident meal with the ethanol
can reduce the peak blood level by about 4 fold at low doses. PKQuest and all the examples are
freely available on the web at  [www.pkquest.com].
Background
The expression "first pass metabolism" (FPM) refers to the
metabolism that an ingested compound undergoes in its
passage through the gut and liver before reaching the sys-
temic circulation. It is a useful concept for a drug because
it provides information about the relative therapeutic ef-
fect of an orally administered drug relative to its intrave-
nous administration (IV). The standard approach to
quantitate FPM is to compare the area under the curve
(AUC) for equal IV and oral doses. The fractional FPM is
then defined as the fractional difference in these two are-
as:
The mathematical basis of this definition is based on the
following arguments: Given some time dependent input
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to the systemic compartment (I(t)), and some removal
rate from the systemic compartment (Q(t)), the integral
over all time of these two rates must be equal:
If the removal rate has a linear dependence on concentra-
tion (Q(t) = KC(t)) then this total input can be related to
the AUC:
Since the total input to the systemic compartment is pro-
portional to the AUC (eq. 3), the fractional difference in
the AUC for an oral and IV dose (eq 1) is a measure of the
amount of the oral drug that never reached the systemic
compartment because of FPM.
This standard operational definition of FPM (eq. 1) is cru-
cially dependent on the assumption that the removal rate
is linear. If this assumption is invalid, then use of this def-
inition can return very misleading results. A recent review
has described the confusion that has resulted from apply-
ing this definition to human ethanol pharmacokinetics, a
compound that has extremely non-linear liver metabo-
lism [1].
For the non-linear case, the intuitive idea that FPM is
equal to the fraction of the absorbed drug that is metabo-
lized in its first pass through the liver is no longer valid
[2]. Consider the case where GI absorption is occurring at
a time when the systemic drug concentration is so high
that the liver metabolism is completely saturated and the
metabolic rate is constant, independent of concentration.
Clearly, at this time, the rate of drug metabolism for an
oral input must be identical to that for an IV input so that
FPM must be zero, even though a large fraction of the ab-
sorbed drug may be metabolized in its first pass through
the liver. This metabolized GI component is simply dis-
placing systemic drug that would otherwise have been
metabolized.
In order to avoid these problems, Lieber and colleagues
[3] introduced a new definition of FPM, based on estimat-
ing the "Peripheral Availability" (PA) of ethanol. The PA
is defined as the total amount of ethanol that reaches the
systemic circulation. Gentry et al. [3] estimated the value
of PA by assuming that the tail of the IV ethanol venous
concentration curve can be approximated by a one com-
partment model in which the ethanol rate of metabolism
(M) was defined by a Michaelis-Menten function (M =
VmC/(Km+C)). The values of Vm and Km are found by
curve fitting, and then PA is defined as the integral of M
from time 0 to a long time when no ethanol is present.
Thus, PA is defined as the total amount of ethanol that
was metabolized from the systemic circulation. The FPM
is then defined as the difference between the PA for an IV
infusion and the PA for the oral intake of an identical
dose. This one compartment definition of FPM has be-
come the standard definition in some laboratories [4].
This definition of FPM of Gentry et al. [3] is inaccurate be-
cause it is a poor approximation to treat ethanol metabo-
lism as a one compartment system (see below). Levitt and
Levitt [2] described an approach to estimate PA using a
two compartment model. They distinguished the liver
ethanol that came directly from the GI tract from the recir-
culating ethanol, and derived an accurate approximation
for this recirculating component. This 2 compartment ap-
proach provides a significantly more accurate (and small-
er) estimate of FPM than the one compartment model.
The 2 compartment model still makes some simplifying
assumptions. These assumptions are eliminated in
PKQuest [5], a new, general-purpose physiologically
based pharmacokinetic (PBPK) software routine. The ap-
proach used by PKQuest is to first use the IV input data to
find the PBPK parameters for ethanol, and then, using
these parameters, solve for the time dependent IV input
function that would produce a blood time course identi-
cal to the time course observed with the orally adminis-
tered drug. This IV input function is a direct measure of
the rate that the oral dose reaches the systemic circulation,
i.e. the PA. Using as input just the PBPK parameters and
the blood ethanol levels produced by an oral dose,
PKQuest outputs (in both tabular and graphical form) the
time course of the intestinal absorption and the PA (see
[5] for the mathematical and computational details).
The difficulty in defining the FPM of ethanol has created
a controversy over the question of the magnitude of etha-
nol metabolism that occurs in the stomach before reach-
ing the liver [1]. It has been observed that the "FPM" is
significantly reduced when ethanol is infused intraduode-
nally compared to the standard oral administration and
this difference has been interpreted as representing gastric
mucosal metabolism [6–8]. Clearly, if there are errors in
the measurement of FPM then this estimate of gastric me-
tabolism may be spurious. In addition to providing a val-
ue for FPM, PKQuest also provides a direct measurement
of the rate and amount of the orally administered solute
that reaches the liver. In this paper, PKQuest will be ap-
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plied to investigations of human ethanol pharmacokinet-
ics, providing information about the FPM; the time course
of intestinal absorption, and the total amount of ethanol
reaching the liver. This is the first human PBPK model for
ethanol incorporating intestinal absorption and FPM. Pis-
tino and Conolly [9] have previously developed a rat
PBPK that quantitated ethanol FPM.
The PKQuest program and all the examples used here are
freely available on the WEB at  [www.pkquest.com].
Methods
PBPK program and its assumptions
PKQuest [5] was used for all the analysis in this paper. All
the figures shown in this paper are direct copies (in jpeg
format) of standard PKQuest output. PKQuest makes sev-
eral simplifying assumptions (see [5] for details). It is as-
sumed that each organ can be modeled as a single well-
stirred compartment. In addition, for the two solutes in-
vestigated in this paper (D2O and ethanol) it is also as-
sumed that the blood-tissue exchange is flow limited so
that the unbound water concentration in the tissue is
equal to that in the vein leaving the tissue. This is clearly
an approximation and effects such as diffusion gradients,
countercurrent exchange and heterogeneous organ blood
flows [10–12] will produce small deviations from this as-
sumption.
Standard human parameters
The PBPK parameters used here are identical to those used
in all the other applications of PKQuest [5,13,14]. The
procedures used for choosing and refining these parame-
ters has been described in [5]. Table 1 lists the organ
weights (Kg) and blood flows (liters/min/Kg) for the
standard 70 Kg human. The "liver" flow is the hepatic
blood flow; "portal" refers to the portal vein blood flow
and to the organs drained by the portal vein (stomach,
small and large intestine, spleen and pancreas); "bone" re-
fers to the inert component of bone, cartilage etc. in which
it is assumed there is no solute distribution or blood flow;
and "other" are all the other organs with a flow and
weight adjusted to account for the total body weight (70
Kg) and the total default cardiac output (6.06 liters/min).
These organ weights are for the default value of 20% body
fat. They are scaled depending on the value of "Fat" that is
input. For a complete listing of all parameters and con-
stants used in PKQuest, download the file gensolve.mws
from the PKQuest web site  [www.pkquest.com] and view
the routines "standardman()" and "defaultpar()".
Experimental data
The D2O data was obtained from the measurements of the
Schloerb et al. [15] of the arterial serum concentration af-
ter a 15 second bolus injection. The results are for one ex-
periment on one male subject (J.O., total body water of
48.0 liters, Table 1I[15]). The amount of D2O injected was
back calculated from the total body water and the concen-
tration after 90 minutes when the D2O had equilibrated.
A baseline ethanol PBPK model was developed based on
the careful and detailed measurements of Norberg et al.
[16] of the simultaneous breath and venous blood con-
centrations for a 30 minute constant IV ethanol infusion.
The concentration calculated from the breath measure-
ments was in good agreement with the direct venous
measurements. The breath results were used here since
they should be closer to the ideal of an arterial sample
then the venous measurements from the cubital vein. The
total body water for each subject in this study was directly
measured using D2O. The time course of the mean values
Table 1: Organ Weights and Blood Flows for Standard Human (70 Kg, 20% Fat)
Organ Weight (Kg) Blood Flow (lit/min/Kg)
Artery 1.1 ----
Vein 4.4 ----
Liver 1.8 0.25
Portal 1.5 0.75
Kidney 0.31 4.0
muscle 33.0 0.0266
brain 1.4 0.56
heart 0.33 0.8
lung 0.536 14.98
skin 2.6 0.12
fat 14 0.056
"other" 4.12 0.054
"bone" 4.90. 0.0BMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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Figure 1
Comparison of the time course of the D 2O arterial blood water concentration (solid line) and the experimental results
(squares) of Schloerb et al. [15] using the default PBPK parameters. A) Default muscle blood flow. B) Twice the default muscle
blood flow.
Figure 2
Comparison of the time course of the ethanol arterial blood water concentration (solid line) and the experimental results of
Norberg et al. [16].BMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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for all 16 subjects (figure 1, [16]) was modeled using
PKQuest. The data of DiPadova et al. [17] was used for the
determination of the rate of absorption of oral ethanol,
along with calculations of the PA and FPM. PKQuest was
applied to the data plotted in figures 1 and 3 of DiPadova
et al. [17] which describe the mean blood ethanol for sub-
jects given 0.15 g/Kg body weight (fig. 1) or 0.3 g/Kg (fig.
3) either orally (with or without a breakfast) or IV on al-
ternate days.
The experimental data points were obtained by using UN-
SCAN-IT (Silk Scientific Corporation) to read the data
from the published figures.
Results
Determination of baseline resting muscle blood flow
The baseline resting muscle blood flow used in PKQuest
was determined by fitting the D2O data of Schoerb et al.
[15] in which the arterial D2O concentration was meas-
ured after a 15 second venous injection of D2O. As de-
scribed previously [5], each compound modeled by
PKQuest is characterized by a short Maple  [www.maple-
soft.com] procedure that lists the model parameters that
are unique for that solute. The procedure for D2O is very
simple because it corresponds to the default case so that
very few parameters have to be input:
d20_schoerb:=proc()
defaultpar():
Wtot:=81.9;
standardhuman(Wtot);
cunit:="10 ml D20";# 10 ml/liter is equivalent to vol%
concunit [artery] :=3;# input data is concentration in
free water
ninput:=1; finput[1]:
table([organ=vein, type=1, rate=27.6, tbeg=0,
tend=.25, csteady=0, padjust=0]);
end proc:
The published data was for subject JO (body weight 81.9
Kg and total body water = 48 liters). This value for total
body water (0.58 liter/Kg) corresponds to a body fat frac-
tion of about 0.2 [18].. This subject was defined as the
"standardhuman" (Fat = 0.2). The values of the water frac-
tion parameter for each tissue compartment in PKQuest
was then adjusted so that the model total body water
equaled this measured value. Since, this man is the
"standardhuman", all the PBPK parameter are input sim-
ply by calls to the "defaultpar()" and "standardhuman()"
procedures. All units in PKQuest are in terms of liters, Kg
and minutes. The parameter "cunit" is the amount unit
(concentration = cunit/liter). Since the D2O concentra-
tion was expressed in vol%, this corresponds to a cunit of
10 ml. The only other information that is needed is con-
cunit [artery] = 3, which indicates that the input data is the
arterial free water concentration. The observed equilibri-
um concentration was 0.144 vol% which corresponds to
a total D2O dose of 69.05 ml, or 276 ml/min for 0.25
minutes, or 27.6 units/min if 1 unit = 10 ml. The output
of PKQuest for this data is shown in fig. 1A (all of the fig-
ures in this paper are taken unmodified from the standard
output of PKQuest). The value for the resting muscle
blood flow (0.0266 Lit/min/Kg) was determined by ad-
justing the flow to optimize the fit to the data using the
Powell minimization procedure of PKQuest. The agree-
ment between the PBPK prediction (solid line) and the ex-
perimental measurements (squares) is very good.
This agreement is sensitive to the value used for the mus-
cle blood flow. For example, fig. 1B shows the effect of
doubling the total muscle blood flow from this default,
best fit, value of 0.0266 to 0.0532 liters/min/kg (increas-
ing the cardiac output from 6.06 to 6.93 liters/min for a
70 Kg man). Muscle blood flow can vary many fold and
one would expect that it would depend on the specific ex-
perimental conditions, such as whether the subject was
supine or ambulatory. In any case, muscle blood flow is
routinely varied when fitting data with PKQuest. This var-
iation may have some physiological significance and/or it
may be just a "fudge factor".
Figure 3
Experimental venous ethanol concentration when a dose of
0.15 gm/Kg ethanol is administered either IV (black) or orally
(red) along with a coincident meal. (Data taken from fig. 1 of
DiPadova et al. [17]).BMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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Standard Ethanol PBPK parameters
The recent measurements of Norberg et al.[16] of the time
course of ethanol blood levels after an IV input were used
to determine the standard ethanol PBPK parameters.
PKQuest was used to model the time course of the mean
blood values of the 16 subjects (8 men, 8 women). This
data was expressed as the concentration in the blood in
units of millimoles/liter of blood water. Both breath and
direct venous sampling results were reported and they
were in very good agreement. The results shown in fig. 2
use the breath measurements since they should be closer
to the ideal of an arterial sample then the venous measure-
ments from the cubital vein. The PKQuest procedure that
is used for ethanol is listed below:
ethanol_norberg:=proc()
defaultpar():
Wtot:=80.0; #Arbitray since ethanol dose is per Kg
standardhuman(Wtot);
Fat:=0.24;
cunit:="millimoles";
concunit [artery]:=3;# concentration in arterial blood
water
Vm [liver]:=2.1:
Km [liver]:=0.04;
fw [lipid]:=1.0/0.074; # = 1/(oil-water partition coeffi-
cient for ethanol)
ninput:=1;finput[1]:
table([organ = vein, type = 1, rate = 23.15, tbeg = 0,
tend = 30, csteady = 0, padjust = 0 ]);
end proc;
The value for Fat (fraction of body weight that is fat) of
0.24 was chosen so that the model subject had a water vol-
ume equal to the average D2O volume of distribution of
the 8 males and 8 females in the study (44.5 liters for 80
Kg human). The muscle blood flow was the same as the
(default) value that was used in fig. 1A for the D2O data.
Since liver metabolism accounts for greater than 95% of
ethanol removal, it is assumed that the liver is the only site
of ethanol elimination [19]. The liver metabolic constants
(Vm = 2.1 millimoles/min for 80 Kg man, Km = 0.04 mM)
were adjusted using the Powell minimization procedure
of PKQuest to give the best fit to the data. These values re-
fer to the free water concentration in the liver (see [5] for
details). There are a number of isoenzymes of alcohol de-
hyrogrenase (ADH) in the human liver and this model
Km of 0.04 mM is consistent with the in vitro Km of 0.048
mM observed for one of these isoenzyme [20]. It is as-
sumed that ethanol distributes in the total body water,
which is the default in PKQuest. The parameter fw [lipid]
= 1/0.074 represents the inverse of the oil/water partition
coefficient and indicates that the equilibrium ethanol
concentration in the body fat is 7.4% of the concentration
in body water [21]. The ethanol dose was 0.4 gm/Kg, giv-
en as a constant 30 minute infusion, corresponding to an
infusion rate of 23.15 millimoles/min for an 80 Kg hu-
man. This Maple procedure (ethanol_norberg) complete-
ly specifies the PBPK parameters. All the other model
parameters are set by the calls to defaultpar() and stand-
ardhuman(). Figure 2 shows the output of PKQuest for
this input. Again, the agreement between the PBPK predic-
tion for the arterial blood concentration (solid line) and
the observed breath data (squares) is quite good.
Quantitation of ethanol first pass metabolism (FPM)
DiPadova et al. [17] measured the blood ethanol in sub-
jects that were given the same dose of ethanol, either IV
(20 minute constant infusion) or orally (over 10 min-
utes), on consecutive days. Figure 3 shows the venous
concentrations as a function of time when a low dose of
ethanol (0.15 g/Kg, equivalent to approximately 12 oz of
beer) was given at the same time as a standard breakfast
either IV (black) or orally (red). The area under the oral
dose curve is only 27% of that for the IV dose. This would
correspond to a FPM of 73% if metabolism was linear –
i.e. only 27% of the orally ingested ethanol reaches the
systemic circulation.. As will be shown below, the actual
FPM is much less than this.
The data in fig. 3 was analyzed using PKQuest. Figure 4A
shows the agreement between the PBPK model and the ve-
nous plasma ethanol concentration for the IV input data.
The PBPK parameters used in this calculation were identi-
cal to those used for figure 2 except that the portal blood
flow was increased 50% because of the coincident meal
[22–24], the liver Vm was increased from 2.1 to 2.5 be-
cause of the induced ethanol effect [25,26] and the muscle
blood flow was doubled. Also, the parameter "concunit
[vein]" was set = 2, indicating that the whole blood ve-
nous concentration was used as the input data.
Figure 4B shows the output of PKQuest when the "findab-
sorption" [5] option was applied to the oral ethanol input
data. Since the IV and oral data used for figs. 4A and 4B
were collected in the same subjects under identical condi-
tions, exactly the same PBPK parameters where used for
both calculations. The open squares show the time courseBMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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of the predicted GI ethanol absorption (amount entering
the liver in the portal vein [5]). The solid line is a 3 param-
eter approximation to the absorption data (absorption at
time t = A [tH/(tH +TH)] where A = total absorption, H =
Hill exponent, T = half time).
It can be seen that the intestinal absorption (fig. 4B) is
complete within about 2 hours. The total predicted ab-
sorption of 250 millimoles is slightly less than the actual
total oral dose of 260 millimoles. Although this is consist-
ent with a small amount of gastric mucosal metabolism
(10 millimoles) it is probably not significant. The calcula-
tion of the total absorption for this low dose is critically
dependent on the accuracy of the venous blood measure-
ments at long times. Since the liver has such a low Km
(0.04 mM), significant amounts of intestinal absorption
could be occurring at long times even though the venous
concentration remained close to zero because of the high
rate of liver clearance. The fluctuation in the total absorp-
tion points at long times in fig. 4B is caused by errors in
these long time blood measurements.
When the "findabsorption" option is used, PKQuest also
routinely calculates the time course of the "Peripheral
Availability" (PA), indicated by the diamonds in fig. 4B
The PA is defined as the equivalent IV input that would
produce the observed venous concentration. Thus, an IV
input with the time course of the diamonds in fig. 4B
would produce exactly the same blood concentration as a
function of time as the GI absorption represented by the
open squares. PA is related to FPM by the relation: FPM =
Total Dose – PA. Thus for the data used for fig. 4B, the PA
of 160 millimoles corresponds to a FPM of 100 milli-
moles (total dose = 260). This represents 38% of the total
dose, about half the value of 73% using the classical AUC
approach.
The FPM for this data was also estimated by using the one
compartment approach [3]. Figure 5A shows the opti-
mized one compartment Michaelis-Menten fit to the tail
of the venous ethanol data (Vm = 8.68 millimoles/min;
Km = 5.46 mM). Figure 5B shows the corresponding fit to
the data of DiPadova etal. [17] for a doubling (0.3 gm/Kg)
of the oral dose (see below). Not surprisingly, a one com-
partment model does not provide an accurate fit to the
ethanol data. The fit is better for the large input dose. Us-
ing these values of Vm and Km, the PA was determined for
the IV and oral dose by assuming a one compartment
model and integrating the liver metabolism (= VmC/
(Km+C) where C equals venous blood concentration)
over the time. For the data of fig. 4, this one compartment
method yielded a FPM of 59%. This is less than the 73%
estimated from the AUC, but significantly greater than the
38% using PKQuest.
DiPadova et al.[17] also measured the blood levels result-
ing from an IV or oral input of a larger ethanol dose (0.3
gm/Kg, total dose of 520 millimoles for the 80 Kg model
subject) and this time they also compared the fasting and
standard breakfast case. Figures 6A and 6B show the
PKQuest output for the IV and oral data when the ethanol
was taken with the same standard meal as was used for the
data in figs. 4A and 4B. The parameters were identical to
those used in figs. 4 except that the liver Vm was reduced
from 2.5 to 2.4 (a different set of subjects were used in the
two sets of experiments). It can be seen from fig. 6B that,
for this higher dose, the total peripheral availability (dia-
monds) is only about 40 millimoles less than the total
Figure 4
PKQuest predictions for an IV or oral input of 0.15 gm/Kg coincident with a standard meal. A) Comparison of the model time
course of the ethanol venous whole blood concentration (solid line) and the experimental results (squares) of DiPadova et al.
[17] for the IV input. B) Predicted total ethanol intestinal absorption (squares) and peripheral availability (diamonds) for the
oral dose. The solid line is a 3 parameter approximation to the model absorption data.BMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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dose of 520 millimoles, corresponding to a fractional
FPM of 7%. This is much less than the FPM value of 44%
determined by using the AUC approach or of 30% using
the one compartment approach. The time course of the in-
testinal absorption for the two doses (compare fig. 4B and
fig. 6B) has the same shape (e.g. same Hill coefficient) but
occurs over a slightly longer time for the larger dose (Hill
half time = 34 minutes for 0.15 gm/Kg dose, and 48 min-
utes for 0.3 gm/Kg dose) presumably because the larger
oral dose was ingested over a longer time (20 minutes for
0.3 gm/Kg versus 10 minutes for 0.15 gm/Kg).
Figures 7A and 7B show the PKQuest output for the same
ethanol dose (0.3 gm/Kg) given to fasting subjects. The
PBPK parameters for these experiments had the portal
blood flow reduced back to the default fasting value. Also,
the liver Vm was reduced back to 2.0, the same value that
was used for the fasting data of Norberg et al [16] in fig 2.
This change in ethanol metabolism is consistent with ear-
lier observations that the rate of ethanol disappearance
from the blood is increased by a coincident meal [25,26].
It can be seen in fig. 7B that the PA (diamonds) is nearly
identical to the GI absorption (squares) so that FPM is
close to zero for the fasting subjects. The AUC and one
compartment approach also indicate a small FPM for this
case.
Figure 5
Optimized one compartment fit to the tail of the venous blood curve for IV ethanol. A) IV input of 0.15 gm/Kg. B) IV input of
0.3 gm/Kg.
Figure 6
Similar to fig. 4 except that the IV dose was 0.3 gm/Kg.BMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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Discussion and conclusions
Validity of the PBPK model
The philosophy behind the use and development of
PKQuest differs from that of the standard PBPK applica-
tions. PBPK models have usually been applied to animal
data where it is possible to accurately measure and control
the relevant parameters (tissue distribution, organ blood
flows, etc.). In contrast, for human studies, not only are
the PBPK parameters poorly characterized, but they are
subject to large individual variation. The impetus behind
PKQuest is to try and develop a "standard" set of human
PBPK parameters that can be applied in the absence of this
detailed information. For this reason, the application of
PKQuest to human data should be regarded as a first ap-
proximation.
Since muscle represents roughly 50% of the body mass,
the muscle blood flow, which can vary 10 fold or more de-
pending on experimental conditions, is the single most
important PBPK parameter and the parameter that limits
the accuracy of the PBPK model. The pharmacokinetics of
D2O (or other tracers of water) are especially simple since
the rate of elimination is very slow and it distributes sim-
ply in the organ water. As shown by figs. 1A and 1B, the
D2O kinetics are sensitive to the muscle blood flow and
the data of Schloerb et al. [15] was used to determine the
resting muscle blood flow value (0.0266 liters/min/Kg)
for the "standardhuman". Although it is problematical to
base such an important parameter on just one set of meas-
urements on one subject, this represents the only pub-
lished measurement of this type that I could find. It is also
an approximation to treat the muscle as a single compart-
ment with a uniform blood flow and in some human
PBPK models [27] two muscle compartments ("resting"
and "working") are included. For the PKQuest modeling,
the muscle blood flow is usually treated as an adjustable
parameter and not as a strictly determined PBPK constant.
The ethanol data that was modeled are the mean values,
averaged over a number of individuals. Because of the
non-linear nature of the pharmacokinetics, it is an ap-
proximation to treat these mean values as representative
of an equivalent "average" human [28]. However, it
should provide a first approximation to the PBPK param-
eters of an "average" human. For the common case where
the published mean values are the only data that is avail-
able, there is no other option.
In the PKQuest modeling of ethanol, it is assumed that
ethanol distributes freely in the tissue water. This seems
like a reasonable assumption given the physical-chemical
properties of ethanol. Measurements of plasma/whole
blood concentration ratios show that this assumption is
valid for red blood cells [29]. However, Norberg et al.
[16,19] has shown that the ethanol volume of distribu-
tion estimated using a 2 compartment model is signifi-
cantly less than the total water volume and they have
reviewed the literature that suggests that the tissue ethanol
distribution may be restricted. Despite this, the agreement
between PKQuest results and the Norberg et al. data (fig-
ure 2) indicate that this assumption is a useful approxima-
tion given the limitations of using the mean data.
Ethanol first pass metabolism and intestinal absorption
The definition of FPM implemented in PKQuest is both
rigorous and intuitive. It is based on defining a time de-
pendent "peripheral availability" (PA) that is equal to the
rate of IV input that would produce the observed time
course of the plasma ethanol concentration. This PA is a
direct quantitative measure of the amount of ethanol that
has reached the systemic circulation. The FPM is then de-
fined as the difference between the total dose adminis-
tered and the PA. The classical procedure of determining
FPM from the AUC (eq.1) markedly overestimates the
FPM. For the case of the small ethanol dose (0.15 gm/Kg)
Figure 7
Similar to fig. 6 except that the subjects were fasting.BMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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taken with a meal, the AUC estimate of fractional FPM of
73% was about twice the value (38%) obtained using
PKQuest. For the higher dose (0.3 gm/Kg) the error was
even larger (44% versus 7%). Although the more recent
one compartment approximation provides a better esti-
mate of FPM, it is still significantly larger than the
PKQuest values (59% versus 38% for 0.15 gm/Kg dose
and 30% versus 7% for 0.3 gm/Kg dose).
The error in both these approximations to FPM results pri-
marily from the fact that the systemic appearance of the
oral ethanol taken with a meal is slow compared to the 20
minute constant infusion that was used to obtain the IV
AUC. Since the liver ethanol metabolism saturates at low
concentrations, the shorter dose will have a higher average
blood concentration and a corresponding lower value of
fractional metabolism. The error would be less if the time
course of the oral absorption was similar to that of the IV
input. This explains why the AUC calculated FPM [17] was
greatly reduced when the subjects were fasting so that the
gastric emptying rate was increased and GI absorption was
more rapid (compare figs. 6B and 7B) and closer to the
rate of IV infusion. The critical dependence of the AUC on
the rate of systemic ethanol input was first pointed out by
Wagner [30]. He showed that the AUC for the oral input
was equal to (or even larger than) the IV AUC if the IV in-
fusion was administered at a slower rate (for 2 hours)
than the rate of intestinal absorption.
Failure to appreciate the problems inherent in using the
AUC or one compartment method to measure FPM has
led to the concept that the gastric mucosa metabolizes a
significant fraction of oral ethanol. Lieber and colleague
observed that the "FPM" was reduced when ethanol was
infused intraduodenally compared to the standard oral
administration and concluded that the difference must
have resulted from gastric mucosa metabolism [6,7]. This
decreased FPM for the intradudenal dose is probably a re-
sult of the much more rapid time course of absorption
when the ethanol is administered directly into the duode-
num. PKQuest provides a direct estimate of the amount of
ethanol reaching the liver. As shown by figs. 4B, 6B and
7B, the total amount of absorbed ethanol reaching the liv-
er does not differ significantly from the total oral dose, in-
dicating that gastric mucosa metabolism is negligible.
In addition to providing a direct measure of PA and FPM,
PKQuest also provides, for the first time, quantitative in-
Figure 8
Comparison of PKQuest prediction of venous blood level (line) versus the experimental data for an oral dose of 0.15 gm/Kg.
The PKQuest intestinal absorption was described by the 3 parameter Hill equation obtained in fig. 6.BMC Clinical Pharmacology 2002, 2 http://www.biomedcentral.com/1472-6904/2/4
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formation about the rate of intestinal absorption of an
orally administered drug that has non-linear metabolism.
A comparison of figs. 6B and 7B provides a dramatic view
of the decreased rate of ethanol absorption when it is ac-
companied by a meal. In the fasting state, ethanol is al-
most completely absorbed within 50 minutes (fig. 7B)
while the ethanol administered with a standard breakfast
takes 3 or more hours for complete absorption (fig. 6B).
Levitt et al.[31] simultaneously measured the rate of hu-
man gastric emptying and ethanol blood concentration
with and without a meal and concluded that the rate of
ethanol absorption was primarily limited by the rate of
gastric emptying. The similarity between the time course
of ethanol absorption seen in figs. 6B and 7B and the gas-
tric emptying time course observed by Levitt, et al. [31]
supports this conclusion.
Simulation of ethanol blood levels after oral intake
Another feature of PKQuest is that it provides a simple in-
terface that can be used to make quantitative predictions
of the blood levels produced by different oral doses. As
shown in figs. 4B, 6B and 7B, PKQuest routinely fits the
time course of the intestinal absorption with a 3 parame-
ter Hill type equation (Absorption at time t = A [tH/(tH
+TH)] where A = total absorption, H = Hill exponent, T =
half time). This 3 parameter input function can then be
used as the input into PKQuest. For example, the intesti-
nal absorption input function that was determined for the
0.3 gm/Kg dose of ethanol ingested with a meal (see fig.
6B) can be used for a model simulation using the follow-
ing settings for finput:
ninput:=1;findabs:=0;finput[1]:=
table([organ=liver, type=3, rate=524, tbeg=0, tend=48.28,
hn=1.87, csteady=0
This corresponds to a total input of 524 millimoles into
the portal vein ("organ = liver") with a Hill coefficient
("hn") of 1.87 and a half time ("tend") of 48.28 minutes.
Figure 8 shows that the simulated blood level for this in-
put function (solid line) slightly underestimates the peak
value, but otherwise is in good agreement with the exper-
imental data (squares) that was used to determine this in-
put function. In Figure 9 this feature is used to illustrate
the dramatic effect of a concomitant meal on the blood
levels resulting from an oral intake. The figure shows the
blood levels for an oral intake of 260 millimoles of etha-
nol (red line, roughly equivalent to one 12 ounce can of
beer); and 2 (green) or 3 (blue) times this dose, all ingest-
ed for a 20 minute time period either with ("fed") or with-
out ("fasted") a meal. The model results for the "fed" case
(fig. 9, left) used the above rate of intestinal absorption
determined from the data in fig. 6B. The "fasted" case (fig.
9, right) used the intestinal absorption rate determined
for the fasting data in fig. 7B (Hill coefficient = 2.6; half
time = 26.84 minutes). In addition, the corresponding
values of liver Vm and portal blood flow for the fed and
fasting conditions are used in this simulation. The influ-
ence of a meal on ethanol blood levels is especially dra-
matic at the low intake dose, decreasing the peak blood
level by about 4 fold.
Competing interests
None declared.
Figure 9
Predicted venous ethanol concentration for an oral intake of 1 (red), 2 (green) or 3 (blue) cans of beer over a 20 minute
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